{"org_id": "T000255528", "org_name_cn": "北京康辰药业股份有限公司", "org_short_name_cn": "康辰药业", "org_name_en": "Beijing Konruns Pharmaceutical Co.,Ltd.", "org_short_name_en": "Konruns", "main_operation_business": "以创新药研发为核心,以临床需求为导向，集研发,生产和销售于一体的创新药企业。", "operating_scope": "　　生产冻干粉针剂、生化原料药、片剂（含抗肿瘤药）；生物医药开发研究；技术推广服务；技术转让、咨询服务（不含中介服务）。（市场主体依法自主选择经营项目，开展经营活动；该企业于2011年09月02日由内资企业变更为外商投资企业。依法须经批准的项目，经相关部门批准后依批准的内容开展经营活动；不得从事国家和本市产业政策禁止和限制类项目的经营活动。）", "district_encode": "110118", "org_cn_introduction": "北京康辰药业股份有限公司是一家坚持以创新药研发为核心、以临床需求为导向，集研发、生产和销售于一体的创新药企业。目前公司产品和在研产品主要专注于血液、骨科以及肿瘤等市场空间较大的领域。公司主要产品“苏灵”是目前国内血凝酶制剂市场唯一的国家一类新药。", "legal_representative": "刘建华", "general_manager": "刘建华", "secretary": "王锡娟(代)", "established_date": 1062518400000, "reg_asset": 160000000.0, "staff_num": 432, "telephone": "86-10-82898898", "postcode": "102206", "fax": "86-10-82898886", "email": "ir@konruns.cn", "org_website": "www.konruns.cn", "reg_address_cn": "北京市密云区经济开发区兴盛南路11号", "reg_address_en": "No. 11 Xingsheng Nan Road\r\nMiyun Economic Development District\r\nBeijing\r\nPRC", "office_address_cn": "北京市昌平区中关村生命科学园科学园路7号院3号楼", "office_address_en": "No. 11 Xingsheng Nan Road\r\nMiyun Economic Development District\r\nBeijing\r\nPRC", "currency_encode": "019001", "currency": "CNY", "listed_date": 1535299200000, "provincial_name": "北京市", "actual_controller": "刘建华 (36.54%)，王锡娟 (9.13%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "王锡娟", "executives_nums": 13, "actual_issue_vol": 40000000.0, "issue_price": 24.34, "actual_rc_net_amt": 891425937.0, "pe_after_issuing": 22.99, "online_success_rate_of_issue": 0.03835219, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}